Stay updated on Nusinersen Safety in SMA Clinical Trial
Sign up to get notified when there's something new on the Nusinersen Safety in SMA Clinical Trial page.

Latest updates to the Nusinersen Safety in SMA Clinical Trial page
- Check4 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check11 days agoChange DetectedThe footer’s revision indicator changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the EMBRACE study details and related links; this indicates the study record is currently inaccessible due to a permissions issue.SummaryDifference20%

- Check53 days agoChange DetectedAn NIH grant/contract identifier was added to the study's list of identifiers, and the page revision was updated from v3.6.5 to v3.6.6. These changes are administrative and reflect metadata updates rather than modifications to study details.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5. This signals a small metadata update rather than a substantive change to the page content.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page revision updated from v3.6.3 to v3.6.4, reflecting a minor page update.SummaryDifference0.0%

Stay in the know with updates to Nusinersen Safety in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nusinersen Safety in SMA Clinical Trial page.